Search results
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors
Guru Focus· 2 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 6 days ago, opens new tab respiratory syncytial virus (RSV) vaccine due to "administrative constraints" and...
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Russell Investments Group Ltd.
ETF DAILY NEWS· 7 days agoRussell Investments Group Ltd. cut its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 28.3% during the 4th quarter, according to its most recent Form 13F ...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 3 days agoThough it might be tempting to invest in stocks that have largely been in tandem with the broader...
Metis Global Partners LLC Trims Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 7 days agoMetis Global Partners LLC reduced its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 19.9% during the fourth quarter, according to the company in its most ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoProofPilot, the industry's premier platform for patient & site automation, guidance, and seamless execution, announces today its double victory alongside esteemed partner Moderna< ...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 6 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 3 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine, mRNA-1345.
FDA delays decision date for Moderna's RSV vaccine - Boston Business Journal
The Business Journals· 6 days agoJust days before its deadline, the U.S. Food and Drug Administration says it's giving itself more...
Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot
Bloomberg· 7 days agoThe biotech’s lackluster new RSV vaccine undercuts the promise of mRNA to revolutionize health care....